José Presa
@liver67.bsky.social
A LiverLover, passionate for my family and science
Reposted by José Presa
How much do you worry about LIRADS-3 and LR-4 lesions in patients with cirrhosis?
HCC incidence rate 110/1000 person-year in patients with LR-3 lesions and 420/1000 for LR-4 lesions
🗝️ importance of close surveillance
Link: journals.lww.com/ajg/fulltext...
Podcast: webfiles.gi.org/podcasts/ajg...
HCC incidence rate 110/1000 person-year in patients with LR-3 lesions and 420/1000 for LR-4 lesions
🗝️ importance of close surveillance
Link: journals.lww.com/ajg/fulltext...
Podcast: webfiles.gi.org/podcasts/ajg...
November 12, 2024 at 3:03 AM
How much do you worry about LIRADS-3 and LR-4 lesions in patients with cirrhosis?
HCC incidence rate 110/1000 person-year in patients with LR-3 lesions and 420/1000 for LR-4 lesions
🗝️ importance of close surveillance
Link: journals.lww.com/ajg/fulltext...
Podcast: webfiles.gi.org/podcasts/ajg...
HCC incidence rate 110/1000 person-year in patients with LR-3 lesions and 420/1000 for LR-4 lesions
🗝️ importance of close surveillance
Link: journals.lww.com/ajg/fulltext...
Podcast: webfiles.gi.org/podcasts/ajg...
Reposted by José Presa
Everything you need to know about #cirrhosis in one picture?
Judge for yourself
pmc.ncbi.nlm.nih.gov/articles/PMC...
#medsky #liversky
Judge for yourself
pmc.ncbi.nlm.nih.gov/articles/PMC...
#medsky #liversky
November 12, 2024 at 12:21 AM
Everything you need to know about #cirrhosis in one picture?
Judge for yourself
pmc.ncbi.nlm.nih.gov/articles/PMC...
#medsky #liversky
Judge for yourself
pmc.ncbi.nlm.nih.gov/articles/PMC...
#medsky #liversky